Objective: To evaluate the long-term clinical outcomes after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) for ostial/shaft lesions in patients with unprotected left main coronary artery (ULMCA). Method: A total of 271 patients with isolated ostial/midshaft lesions in unprotected left main coronary artery who received drug-eluting stents (DES) implantation between January 2003 and July 2009 in Beijing An Zhen Hospital were consecutively enrolled . The endpoints of the study were all-cause death, repeat revascularization, myocardial infarction (MI) and stroke. Cox regression was carried out to analyze the all-cause mortality. Meanwhile, multivariate logistic regression analysis was performed to determine the independent risk factors of all-cause death. Results: The mean age of the patients was (62±10) years, and 201 of them (74.2%) were male. The median follow-up was 12.5 years (interquartile range: 10.1-14.5 years). During the follow-up, 46 patients (17.0%) died, of whom 20 (7.4%) died of a cardiovascular cause. A total of 38 (14.0%) cases suffered a MI, and 15 (5.5%) cases suffered a stroke. Repeat revascularization was performed in 63 (23.2%) cases. Multivariate logistic regression analysis showed that age (HR=1.041, 95%CI: 1.003-1.081, P=0.033), creatinine (HR=1.028, 95%CI:1.014-1.042, P<0.001) and diabetes mellitus (HR=1.924,95%CI: 1.053-3.514, P=0.033) were independent risk factors of all-cause death, whereas left ventricular ejection fraction (LVEF) (HR=0.972, 95%CI:0.953-0.992, P=0.007) was a protective factor. Conclusions: During a median follow-up of 12.5 years, the prognosis of PCI for left main ostium/shaft lesion was good. Age, creatinine and diabetes mellitus are independent risk factors of all-cause death.
目的: 本研究旨在观察经皮冠状动脉介入术(PCI)治疗无保护左主干开口/体部患者长期预后及其危险因素。 方法: 入选2003年1月至2009年7月北京安贞医院行PCI治疗的无保护左主干开口/体部病变组271例。研究终点包括全因死亡、心肌梗死、卒中、再次血运重建。采用Cox比例风险模型对PCI治疗无保护左主干开口/体部病变死亡率进行生存分析,并对全因死亡进行多因素校正分析。 结果: 271例患者年龄(62±10)岁,男性201例(74.2%),随访时间[M(Q1,Q3)] 12.5(10.1,14.5)年,在左主干开口/体部病变患者中,46例患者死亡(17.0%),20例为心源性死亡(7.4%),共38例发生心肌梗死(14.0%),15例发生卒中(5.5%),63例患者再次血运重建(23.2%)。年龄(HR=1.041,95%CI:1.003~1.081,P=0.033)、肌酐(HR=1.028,95%CI:1.014~1.042,P<0.001)、糖尿病(HR=1.924,95%CI:1.053~3.514,P=0.033)是无保护左主干开口/体部病变行PCI术后全因死亡的独立危险因素,左室射血分数(HR=0.972,95%CI:0.953~0.992,P=0.007)是无保护左主干开口/体部病变行PCI术后全因死亡的保护因素。 结论: 在中位数长达12.5年的随访中,PCI治疗无保护左主干开口/体部患者长期预后尚可,年龄、血肌酐、糖尿病是全因死亡的独立危险因素。.